RADIOPHARMACEUTICALS (LUTATHERA and PLUVICTO)

Awarded Limited / Sole Source Justification Posted

Solicitation number
W81K0024D0004
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
W81K0024D0004 Federal IDV award
Place of performance
Jbsa Ft Sam Houston, Texas 78234, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of the Army Medical Command has issued a Justification and Approval (J&A) for a sole source contract with Advanced Accelerator Applications USA (AAA) to provide the radiopharmaceuticals Lutathera and Pluvicto to the Brooke Army Medical Center. The Department of Nuclear Medicine at BAMC requires these two FDA-approved products for the treatment of specific types of cancer. AAA is the sole manufacturer of these products, and a sources sought notice resulted in no other potential suppliers. The contract is projected to be awarded in September 2024 with an estimated total value, contingent on FY25 funding. The J&A cites the authority under 10 USC 3204(a)(1) and FAR 6.302-1 for the sole source award.

Notice text

J&A for Lutathera and Pluvicto in support of Brooke Army Medical Center. 

Awarded contract W81K0024D0004 to unknown vendor for unknown amount on 2024-09-18.

Files

File Type Posted
JA_Lutathera and Pluvicto_Redacted..pdf PDF

Notice history

Notice Type Posted
This notice Latest Limited / Sole Source Justification
RADIOPHARMACEUTICALS (LUTATHERA and PLUVICTO) Latest special notice Special Notice
RADIOPHARMACEUTICALS (LUTATHERA and PLUVICTO) Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--VA Long Beach Pylarify NAICS 325412 Veterans Integrated Service Network 22 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity